Sihuan Pharmaceutical Holdings Group Ltd SHPHY 上一季度的收入表现如何?
Sihuan Pharmaceutical Holdings Group Ltd 的收入预期是多少?
Sihuan Pharmaceutical Holdings Group Ltd 的盈利质量评分是多少?
Sihuan Pharmaceutical Holdings Group Ltd 何时发布财报?
Sihuan Pharmaceutical Holdings Group Ltd 的预期收益是多少?
Sihuan Pharmaceutical Holdings Group Ltd 是否超出收益预期?
关键数据
前收盘价
--
开盘价
--
当日区间
-
52周范围
-
交易量
--
平均成交量
--
每股收益(TTM)
--
股息收益率
--
市值
--
什么是 SIHUAN PHARMACEUTICAL HOLD GP L?
Sihuan Pharmaceutical Holdings Group Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. The company is headquartered in Beijing, Beijing and currently employs 2,767 full-time employees. The company went IPO on 2010-10-28. The firm operates its business through three segments. The Medical Aesthetic Products segment includes the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care and others to provide non- or minimally invasive medical aesthetic comprehensive solutions. The Innovative Medicine and Other Medicine segment is engaged in the research and development and commercialization of innovative medicine in the disease fields of diabetes, breast cancer, digestion disorders, oncology and non-alcoholic steatohepatitis and others. The Generic Medicine segment is engaged in the production and sale of generic medicine including Kelin’ao and other products. The firm conducts its business in the domestic and overseas markets.